Paolo Rocco

617 total citations
31 papers, 395 citations indexed

About

Paolo Rocco is a scholar working on Economics and Econometrics, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Paolo Rocco has authored 31 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 6 papers in Pharmaceutical Science and 5 papers in Molecular Biology. Recurrent topics in Paolo Rocco's work include Pharmaceutical Economics and Policy (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Biosimilars and Bioanalytical Methods (5 papers). Paolo Rocco is often cited by papers focused on Pharmaceutical Economics and Policy (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Biosimilars and Bioanalytical Methods (5 papers). Paolo Rocco collaborates with scholars based in Italy, Czechia and Argentina. Paolo Rocco's co-authors include Paola Minghetti, Umberto M. Musazzi, Silvia Franzè, Francesco Cilurzo, Lucia Del Vecchio, Francesco Locatelli, Antonella Casiraghi, Francesca Selmin, Veniero Gambaro and Gabriella Roda and has published in prestigious journals such as The Science of The Total Environment, International Journal of Pharmaceutics and International Journal of Environmental Research and Public Health.

In The Last Decade

Paolo Rocco

29 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Rocco Italy 13 78 69 61 57 46 31 395
Hussain Ali Pakistan 13 42 0.5× 23 0.3× 36 0.6× 14 0.2× 115 2.5× 35 461
Xiaojian Jiang China 11 56 0.7× 19 0.3× 60 1.0× 24 0.4× 172 3.7× 18 418
André Farkouh Austria 8 23 0.3× 53 0.8× 54 0.9× 16 0.3× 62 1.3× 17 394
Xiaohui Jiang United States 12 64 0.8× 24 0.3× 235 3.9× 88 1.5× 153 3.3× 29 777
Charles Bon United States 10 40 0.5× 57 0.8× 218 3.6× 9 0.2× 53 1.2× 24 471
Yang Mai China 15 27 0.3× 53 0.8× 66 1.1× 7 0.1× 98 2.1× 34 439
Carmel Kealey Ireland 14 79 1.0× 65 0.9× 4 0.1× 35 0.6× 139 3.0× 29 711
Yuexi Wang United States 11 25 0.3× 49 0.7× 8 0.1× 16 0.3× 131 2.8× 46 386
Yue Gao China 17 172 2.2× 29 0.4× 47 0.8× 13 0.2× 232 5.0× 68 795

Countries citing papers authored by Paolo Rocco

Since Specialization
Citations

This map shows the geographic impact of Paolo Rocco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Rocco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Rocco more than expected).

Fields of papers citing papers by Paolo Rocco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Rocco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Rocco. The network helps show where Paolo Rocco may publish in the future.

Co-authorship network of co-authors of Paolo Rocco

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Rocco. A scholar is included among the top collaborators of Paolo Rocco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Rocco. Paolo Rocco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dorati, Rossella, Donato Cosco, Luigi Battaglia, et al.. (2025). On-body drug delivery systems: State-of-the-art technologies, clinical application, and future perspectives. Drug Discovery Today. 30(9). 104441–104441.
2.
Musazzi, Umberto M., et al.. (2025). Back to gene therapy: bringing the EU regulation into the future. Drug Discovery Today. 30(8). 104424–104424. 1 indexed citations
3.
Zanchettin, Andrea Maria, et al.. (2024). Optimal model-based path planning for the robotic manipulation of deformable linear objects. Robotics and Computer-Integrated Manufacturing. 92. 102891–102891. 2 indexed citations
4.
Zanchettin, Andrea Maria, et al.. (2024). Potential Field-Based Online Path Planning for Robust Cable Routing. Virtual Community of Pathological Anatomy (University of Castilla La Mancha). 7558–7564.
5.
Musazzi, Umberto M., et al.. (2023). Marketing authorisations for unmet medical needs: A critical appraisal of regulatory pathways in the European Union. International Journal of Pharmaceutics. 642. 123193–123193. 4 indexed citations
6.
Montini, Elias, et al.. (2022). An IIoT Platform For Human-Aware Factory Digital Twins. Procedia CIRP. 107. 661–667. 20 indexed citations
7.
Rocco, Paolo, Umberto M. Musazzi, & Paola Minghetti. (2022). Medicinal products meet medical devices: Classification and nomenclature issues arising from their combined use. Drug Discovery Today. 27(10). 103324–103324. 3 indexed citations
9.
Franzè, Silvia, Francesca Selmin, Paolo Rocco, et al.. (2020). Preserving the Integrity of Liposomes Prepared by Ethanol Injection upon Freeze-Drying: Insights from Combined Molecular Dynamics Simulations and Experimental Data. Pharmaceutics. 12(6). 530–530. 16 indexed citations
10.
Rocco, Paolo, Ivano Eberini, Umberto M. Musazzi, Silvia Franzè, & Paola Minghetti. (2019). Glatiramer acetate: A complex drug beyond biologics. European Journal of Pharmaceutical Sciences. 133. 8–14. 11 indexed citations
11.
Musazzi, Umberto M., Francesca Selmin, Silvia Franzè, et al.. (2018). Poly(methyl methacrylate) salt as film forming material to design orodispersible films. European Journal of Pharmaceutical Sciences. 115. 37–42. 22 indexed citations
12.
Minghetti, Paola, Umberto M. Musazzi, Rossella Dorati, & Paolo Rocco. (2018). The safety of tattoo inks: Possible options for a common regulatory framework. The Science of The Total Environment. 651(Pt 1). 634–637. 15 indexed citations
13.
Rocco, Paolo, et al.. (2018). Biosimilar switching and related medical liability. Journal of Forensic and Legal Medicine. 55. 93–94. 9 indexed citations
14.
Musazzi, Umberto M., et al.. (2018). Do laws impact opioids consumption? A breakpoint analysis based on Italian sales data. Journal of Pain Research. Volume 11. 1665–1672. 7 indexed citations
15.
Rocco, Paolo, Francesco Cilurzo, Paola Minghetti, Giulio Vistoli, & Alessandro Pedretti. (2017). Molecular Dynamics as a tool for in silico screening of skin permeability. European Journal of Pharmaceutical Sciences. 106. 328–335. 19 indexed citations
16.
Rocco, Paolo, Francesco Cilurzo, Paola Minghetti, Giulio Vistoli, & Alessandro Pedretti. (2017). Simulation data for an estimation of the maximum theoretical value and confidence interval for the correlation coefficient. Data in Brief. 14. 291–294. 4 indexed citations
17.
Casiraghi, Antonella, Umberto M. Musazzi, Paolo Rocco, Silvia Franzè, & Paola Minghetti. (2016). Topical Treatment of Infantile Haemangiomas: A Comparative Study on the Selection of a Semi-Solid Vehicle. Skin Pharmacology and Physiology. 29(4). 210–219. 21 indexed citations
18.
Minghetti, Paola, Paolo Rocco, Francesco Cilurzo, Lucia Del Vecchio, & Francesco Locatelli. (2011). The regulatory framework of biosimilars in the European Union. Drug Discovery Today. 17(1-2). 63–70. 45 indexed citations
19.
Minghetti, Paola, Paolo Rocco, Lucia Del Vecchio, & Francesco Locatelli. (2010). Biosimilars and Regulatory Authorities. Nephron Clinical Practice. 117(1). c1–c7. 27 indexed citations
20.
Lairion, Fabiana, et al.. (1997). In vitroCiprofloxacin release from poly(lactide-co-glycolide) microspheres. Journal of Microencapsulation. 14(2). 155–161. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026